- Home
- CDRE vs OCUL Comparison
CDRE vs OCUL Comparison
Compare CDRE & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDRE
- OCUL
- Stock Information
- Founded
- CDRE 2012
- OCUL 2006
- Country
- CDRE United States
- OCUL United States
- Employees
- CDRE N/A
- OCUL N/A
- Industry
- CDRE Industrial Specialties
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- CDRE Health Care
- OCUL Health Care
- Exchange
- CDRE Nasdaq
- OCUL Nasdaq
- Market Cap
- CDRE 1.4B
- OCUL 1.2B
- IPO Year
- CDRE 2021
- OCUL 2014
- Fundamental
- Price
- CDRE $33.56
- OCUL $7.00
- Analyst Decision
- CDRE Strong Buy
- OCUL Strong Buy
- Analyst Count
- CDRE 4
- OCUL 7
- Target Price
- CDRE $39.75
- OCUL $16.71
- AVG Volume (30 Days)
- CDRE 193.6K
- OCUL 940.9K
- Earning Date
- CDRE 03-04-2025
- OCUL 03-10-2025
- Dividend Yield
- CDRE 1.13%
- OCUL N/A
- EPS Growth
- CDRE N/A
- OCUL N/A
- EPS
- CDRE 0.83
- OCUL N/A
- Revenue
- CDRE $516,159,999.00
- OCUL $61,442,000.00
- Revenue This Year
- CDRE $18.89
- OCUL $11.40
- Revenue Next Year
- CDRE $10.39
- OCUL $13.58
- P/E Ratio
- CDRE $40.56
- OCUL N/A
- Revenue Growth
- CDRE 7.18
- OCUL 6.45
- 52 Week Low
- CDRE $29.19
- OCUL $4.06
- 52 Week High
- CDRE $40.28
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- CDRE 35.77
- OCUL 31.92
- Support Level
- CDRE $34.91
- OCUL $7.14
- Resistance Level
- CDRE $35.87
- OCUL $7.42
- Average True Range (ATR)
- CDRE 1.04
- OCUL 0.37
- MACD
- CDRE -0.43
- OCUL -0.02
- Stochastic Oscillator
- CDRE 0.00
- OCUL 0.76
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.